Related Experiment Video
Updated: Dec 15, 2025

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Antibody microarray analysis of serum inflammatory cytokines in patients with calcific aortic valve disease
Bo Fu1, Yuhui Zhang1,2, Qingliang Chen1
1Department of Cardiovascular Surgery, Tianjin Chest Hospital, Tianjin, China.
Insights
Calcific aortic valve disease (CAVD) involves inflammation. Researchers identified four key inflammatory markers, B-Lymphocyte Chemoattractant (BLC), Interleukin (IL)-12p40, monokine inducible by γ interferon (MIG), and Macrophage inflammatory protein (MIP)-1delta, as potential indicators for CAVD assessment.
Area of Science:
- Cardiovascular Research
- Immunology
- Biomarker Discovery
Background:
- Calcific aortic valve disease (CAVD) is a prevalent condition in the elderly, leading to aortic valve stenosis and significant mortality.
- CAVD pathogenesis involves inflammation, apoptosis, lipid deposition, and matrix remodeling.
- Current understanding necessitates novel diagnostic markers for CAVD.
Purpose of the Study:
- To investigate and analyze the expression of serum inflammatory factors in patients with CAVD.
- To identify potential serum biomarkers for the early detection and assessment of CAVD.
Main Methods:
- A cohort of 258 patients was categorized into control, coronary artery disease (CAD), and CAVD groups.
- Serum adipokine, cytokine, and chemokine profiles were analyzed using antibody microarray techniques.
- Validation of key markers was performed using Real-time PCR, Western blot, and flow cytometry.
Main Results:
- Significantly elevated levels of B-Lymphocyte Chemoattractant (BLC), Interleukin (IL)-12p40, monokine inducible by γ interferon (MIG), and Macrophage inflammatory protein (MIP)-1delta were observed in the CAVD group compared to control and CAD groups.
- These four inflammatory markers were confirmed to originate from peripheral blood mononuclear cells.
- The identified markers showed differential expression patterns relevant to CAVD.
Conclusions:
- BLC, IL-12p40, MIG, and MIP-1delta demonstrate potential as reliable serum biomarkers for CAVD.
- These findings may offer significant clinical implications for CAVD diagnosis and management.
- Further research can explore the therapeutic targeting of these inflammatory pathways.
Background:
Calcific aortic valve disease (CAVD) is a slowly progressive pathologic process associated with significant morbidity and mortality, CAVD is the most common valve heart disease in the elderly and a leading cause of aortic valve stenosis. Multiple steps characterize the process: inflammation, cell apoptosis, lipid deposition, renin-angiotensin system activation, extracellular matrix remodeling, and bone formation. This paper focuses on detecting and analyzing the expression of serum inflammatory factors in CAVD by antibody microarray techniques.
Methods:
In this study, a total of 258 patients were included at Tianjin Chest Hospital between January 2017 and December 2018, subjects were divided into three groups: control, coronary artery disease (CAD), and CAVD. Blood samples were collected, and adipokine/cytokine/chemokine serum profiles were measured by antibody arrays.
Results:
These data suggest that B-Lymphocyte Chemoattractant (BLC), Interleukin (IL)-12p40, monokine inducible by γ interferon (MIG), and Macrophage inflammatory protein (MIP)-1delta were significantly increased in CAVD compared to control or CAD. Furthermore, Real-time quantified PCR, Western blot assay, and Flow cytometer detection showed that these four cytokines/chemokines were from peripheral blood mononuclear cells.
Conclusions:
These findings suggest that BLC, IL-12p40, MIG, and MIP-1delta can be used as a marker to assess CAVD, which could have significant clinical implications.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
The JAK-STAT Signaling Pathway

